UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045980
Receipt number R000052381
Scientific Title A study to evaluate the effect of food ingredient in healthy adult on the knee discomfort -Placebo-controlled, randomized, double-blind, parallel-group comparative method
Date of disclosure of the study information 2021/11/04
Last modified on 2021/11/04 16:57:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study to evaluate the effect of food ingredient in healthy adult on the knee discomfort -Placebo-controlled, randomized, double-blind, parallel-group comparative method

Acronym

A study to evaluate the effect of food ingredient in healthy adult on the knee discomfort -Placebo-controlled, randomized, double-blind, parallel-group comparative method

Scientific Title

A study to evaluate the effect of food ingredient in healthy adult on the knee discomfort -Placebo-controlled, randomized, double-blind, parallel-group comparative method

Scientific Title:Acronym

A study to evaluate the effect of food ingredient in healthy adult on the knee discomfort -Placebo-controlled, randomized, double-blind, parallel-group comparative method

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect of test food intake for 12 consecutive weeks on knee discomfort using placebo as a control

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Knee function questionnaire

Key secondary outcomes

Blood test


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Ingestion of test food (research food)

Interventions/Control_2

Ingestion of placebo

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Japanese adult males and females between 20 and 70 years of age
(2) Subjects who have been judged to be healthy by a physician
(3) Of the above subjects, those who have experienced discomfort in the knee from the past year to the present (at the time of screening)

Key exclusion criteria

(1)Subjects who are taking medication or visiting a hospital
(2)Subjects with a history of serious diseases
(3) Subjects who have participated in other clinical trials within the past month
(4) Subjects who are binge drinkers or have an irregular diet
(5) Subjects who are judged as inappropriate by the physician in charge of the study
(6) Subjects with food allergies or drug allergies
(7) Subjects who have been diagnosed as severe (Grade II or higher) by the Kellgren-Laurence classification

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Ryosuke
Middle name
Last name Mastuoka

Organization

Kewpie Corporation

Division name

R&D Division

Zip code

1820002

Address

2-5-7, Sengawa-cho, Chofu-shi, Tokyo

TEL

03-5384-7759

Email

ryosuke_matsuoka@kewpie.co.jp


Public contact

Name of contact person

1st name Tomomi
Middle name
Last name Tanaka

Organization

Kewpie Corporation

Division name

R&D Division

Zip code

1820002

Address

2-5-7, Sengawa-cho, Chofu-shi, Tokyo

TEL

03-5384-7759

Homepage URL


Email

tomomi_tanaka@kewpie.co.jp


Sponsor or person

Institute

Hokkaido University of Education
Kewpie Corporation

Institute

Department

Personal name



Funding Source

Organization

Kewpie Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hokkaido University of Education Ethics Review Committee

Address

2-34-1, Midorigaoka, Iwamisawa, Hokkaido

Tel

0126-32-0214

Email

iwa-somu@j.hokkyodai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 11 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 03 Month 26 Day

Date of IRB

2021 Year 03 Month 26 Day

Anticipated trial start date

2021 Year 12 Month 11 Day

Last follow-up date

2022 Year 03 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 11 Month 04 Day

Last modified on

2021 Year 11 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052381